Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712. In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712. State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712. Case and Commentary Jan 2020 How Should Public Health Officials Respond When Important Local Rituals Increase Risk of Contagion? Esther Mokuwa, MSc and Paul Richards, PhD, MA During one 2014 Ebola epidemic, arrival of “safe burial” teams was often delayed. Some buried their loved ones themselves, which undermined containment efforts. AMA J Ethics. 2020;22(1):E5-9. doi: 10.1001/amajethics.2020.5. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. State of the Art and Science Apr 2006 Surveillance of Infectious Diseases Is Information for Action Mark S. Dworkin, MD, MPHTM Virtual Mentor. 2006;8(4):223-226. doi: 10.1001/virtualmentor.2006.8.4.cprl1-0604. Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Case and Commentary Feb 2007 Risks and Benefits of the New Medical Imaging Enterprise Judy Illes, PhD and Scott W. Atlas, MD Virtual Mentor. 2007;9(2):99-103. doi: 10.1001/virtualmentor.2007.9.2.ccas3-0702. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712.
In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712.
State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712.
Case and Commentary Jan 2020 How Should Public Health Officials Respond When Important Local Rituals Increase Risk of Contagion? Esther Mokuwa, MSc and Paul Richards, PhD, MA During one 2014 Ebola epidemic, arrival of “safe burial” teams was often delayed. Some buried their loved ones themselves, which undermined containment efforts. AMA J Ethics. 2020;22(1):E5-9. doi: 10.1001/amajethics.2020.5.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
State of the Art and Science Apr 2006 Surveillance of Infectious Diseases Is Information for Action Mark S. Dworkin, MD, MPHTM Virtual Mentor. 2006;8(4):223-226. doi: 10.1001/virtualmentor.2006.8.4.cprl1-0604.
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.
Case and Commentary Feb 2007 Risks and Benefits of the New Medical Imaging Enterprise Judy Illes, PhD and Scott W. Atlas, MD Virtual Mentor. 2007;9(2):99-103. doi: 10.1001/virtualmentor.2007.9.2.ccas3-0702.